MX9705331A - Derivados ciclicos de sulfona. - Google Patents
Derivados ciclicos de sulfona.Info
- Publication number
- MX9705331A MX9705331A MX9705331A MX9705331A MX9705331A MX 9705331 A MX9705331 A MX 9705331A MX 9705331 A MX9705331 A MX 9705331A MX 9705331 A MX9705331 A MX 9705331A MX 9705331 A MX9705331 A MX 9705331A
- Authority
- MX
- Mexico
- Prior art keywords
- sulfone derivatives
- cyclic sulfone
- formula
- scleritis
- sepsis
- Prior art date
Links
- -1 Cyclic sulfone Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 208000030507 AIDS Diseases 0.000 abstract 1
- 206010014989 Epidermolysis bullosa Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010039705 Scleritis Diseases 0.000 abstract 1
- 206010040047 Sepsis Diseases 0.000 abstract 1
- 206010040070 Septic Shock Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
- 230000036303 septic shock Effects 0.000 abstract 1
- 230000036269 ulceration Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/44—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Un compuesto de formula (Ver Formula); en la que n, q, p, X, Y, Z y Ar son como se han definido en la presente, util en el tratamiento de artritis, cáncer, ulceracion de tejidos, restenosis, enfermedad periodontal, epidermolisis ampoilosa, escleritis u otras enfermedades caracterizadas pro actividad de metaloproteinasas matriciales, así como SIDA, sepsis, choque séptico u otras enfermedades que implican la produccion de TNF.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2165296P | 1996-07-12 | 1996-07-12 | |
| US021652 | 1996-07-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9705331A true MX9705331A (es) | 1998-08-30 |
| MXPA97005331A MXPA97005331A (es) | 1998-11-12 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| EP0818442A2 (en) | 1998-01-14 |
| JPH1095764A (ja) | 1998-04-14 |
| CA2210056A1 (en) | 1998-01-12 |
| EP0818442A3 (en) | 1998-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY113586A (en) | Aylsulfonylamino hydroxamic acid derivatives | |
| EP0818442A3 (en) | Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor | |
| DE69805473D1 (de) | Arylsulfonylaminohydroxamsäurederivate | |
| AP9801174A0 (en) | Cyclic sulfone derivatives. | |
| MY121754A (en) | Arylsulfonylamino hydroxamic acid derivatives | |
| MY120235A (en) | Aryloxyarylsulfonylamino hydroxamic acid derivatives | |
| PT738107E (pt) | Inibidores da sintese de acidos gordos como agentes antimicrobianos | |
| MY139235A (en) | One step process for the preparation of anticonvulsant derivatives | |
| UA84407C2 (en) | Acetyl 2-hydroxy-1,3 diaminoalkanes | |
| IL143747A0 (en) | Substituted aryl or heteroarylamides having retinoid-like biological activity | |
| BG105527A (en) | Nonsteroid antiinflammatories | |
| GT200200016A (es) | Inhibidores de benzotiadiazina de metaloproteinasas de la matriz | |
| DE60008862D1 (de) | Thienopyrimidin verbindungen, ihre herstellung und verwendung | |
| NZ335383A (en) | Epothilone C,D,E and F for plant protection and cytostatic effects shown in kidney cells | |
| PL371046A1 (en) | Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors | |
| ZA9710796B (en) | Oxyiminopregnanecarbolactones. | |
| AU1058492A (en) | Improvements in or relating to organic compounds | |
| AU7040598A (en) | Glycosaminoglycans having high antithrombotic activity | |
| ES2131297T3 (es) | Nuevos derivados de bencenosulfonilamina como inhibidores de la accion il-1. | |
| IT1309416B1 (it) | Terreno artificiale ottenuto da un processo di compostaggio con alghe- fanghi di depurazione civili - gessi chimici tioxide. | |
| DE60210769D1 (de) | Verwendung von bicyklischen verbindungen für die behandlung von alzheimer | |
| ECSP982620A (es) | Derivados de acidos ariloxiarilsulfonilamino hidroxamicos | |
| NO974870L (no) | Nye substituerte tetrahydropyrano £3,2-d|- oxazoloner, fremgangsmåte ved fremstilling av dem og farmasöytiske sammensetninger som inneholder dem | |
| IT1275869B1 (it) | Impianto di trattamento biologico di acque reflue | |
| ECSP961719A (es) | Derivados del acido aril sulfonil hidroxamico |